{"product_id":"fda-s-february-2025-guidance-update-key-changes-for-irbs-and-clinical-investigators-2026-10-03","title":"FDA's February 2025 Guidance Update: Key Changes for IRBs and Clinical Investigators","description":"\u003cp class=\"header-block-grey\"\u003eCourse Description\u003c\/p\u003e \u003cp\u003eThis web seminar will review the FDA's February 2025 updates to its guidance for Institutional Review Boards (IRBs) and clinical investigators. Learners will explore the key revisions, new regulatory expectations, and practical implications for IRB oversight and investigator responsibilities in depth, and will gain a clear understanding of compliance requirements and best practices for implementing these changes in clinical research by the end of the course. \u003c\/p\u003e \u003cp class=\"header-block-grey\"\u003eLearning Objectives\u003c\/p\u003e \u003cul type=\"disc\"\u003e \u003cli\u003eIdentify the major updates in the FDA's February 2025 guidance for IRBs and clinical investigators\u003c\/li\u003e \u003cli\u003eExplain the regulatory rationale behind the new guidance changes and their impact on clinical research oversight\u003c\/li\u003e \u003cli\u003eAssess how the updated guidance affects IRB review processes and nvestigator responsibilities\u003c\/li\u003e \u003cli\u003eDevelop strategies for ensuring compliance with the revised FDA expectations in clinical trials\u003c\/li\u003e \u003cli\u003eApply best practices for implementing the new guidance in institutional and investigator-led research settings\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"header-block-grey\"\u003eWho Should Attend\u003c\/p\u003e \u003cul type=\"disc\"\u003e \u003cli\u003eIRB Members and Administrators\u003c\/li\u003e \u003cli\u003eClinical Investigators and Study Coordinators\u003c\/li\u003e \u003cli\u003eRegulatory Affairs Professionals\u003c\/li\u003e \u003cli\u003eResearch Compliance Officers\u003c\/li\u003e \u003cli\u003eSponsor and Contract Research Organization (CRO) Personnel\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"header-block-grey\"\u003eInstructor\u003c\/p\u003e \u003cp\u003eElizabeth Ronk Nelson, M.P.H.\u003c\/p\u003e \u003cp\u003e\u003cspan class=\"purple-link\"\u003e\u003ca href=\"https:\/\/stage.barnettinternational.com\/instructor-biographies\" title=\"Click here for complete trainer biographies\"\u003eClick here for complete trainer biographies\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e \u003cp class=\"header-block-grey\"\u003eRegistration Fees\u003c\/p\u003e \u003cp\u003e$835*\u003c\/p\u003e \u003cp\u003e*Includes up to 20 participants per login at a single location. All participants (up to 20) are eligible for \"Certificates of Attendance,\" and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional logins for other locations, please call +1 781.972.5400 or toll-free in the U.S. 800.856.2556, or email customer.service@barnettinternational.com for pricing.\u003c\/p\u003e \u003cp class=\"header-block-grey\"\u003eAccreditation Information\u003c\/p\u003e \u003cp\u003eBarnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 2 hours (0.2 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will issue a receipt of completion for earned CEUs within three weeks of program completion. ACPE#: 0778-0000-25-052-L99-P. Released: 8\/25. \u003c\/p\u003e \u003cp align=\"center\"\u003e\u003cspan class=\"bold\"\u003eHold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471. \u003c\/span\u003e \u003cfont color=\"black\" face=\"Verdana, Arial, Helvetica, sans-serif\" size=\"-1\"\u003e \u003c\/font\u003e \u003c\/p\u003e","brand":"Barnett International","offers":[{"title":"Commercial","offer_id":53375371411821,"sku":"BI17463","price":450.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.barnettinternational.com\/products\/fda-s-february-2025-guidance-update-key-changes-for-irbs-and-clinical-investigators-2026-10-03","provider":"Barnett International ","version":"1.0","type":"link"}